Compensation Models and Incentives: Where Payment Design Becomes Lay Control

A physician reviewing an employment offer reads the compensation section closely and the professional-independence clause quickly. The compensation section determines their income; the independence clause is boilerplate.

That ordering is backwards, because in California the two provisions interact. Business and Professions Code section 2400 (law.justia.com) provides that corporations and other artificial legal entities shall have no professional rights, privileges, or powers — and section 2052 (leginfo.legislature.ca.gov) prohibits practicing medicine without a license.

The Medical Board’s own enforcement material (official source) states the policy plainly: California has a strong long-standing public policy against permitting lay persons to practise any of the medical arts or to exercise control over decisions made by healing arts practitioners, and the bar to corporate practice is essentially designed to protect the public from possible abuses stemming from the commercial exploitation of the practice of medicine.

Read that as being about control rather than title, and compensation design becomes the central question rather than a commercial detail. This article works through the common models, where each sits against the prohibition, and what a physician should look for in an offer.

What the doctrine actually prohibits

Precision here matters, because the doctrine is described loosely and the loose version is either alarming or reassuring depending on who is describing it.

The statutory core is short. Section 2400 (official source) provides that corporations and other artificial legal entities shall have no professional rights, privileges, or powers. It contains a narrow exception: the licensing authority may, in its discretion and under regulations, grant approval of the employment of licensees on a salary basis by licensed charitable institutions, foundations, or clinics, if no charge for professional services rendered patients is made by any such institution, foundation, or clinic.

Alongside it, section 2052 (official source) prohibits practicing medicine without a valid certificate of licensure.

The Board’s enforcement material (official source) ties the two together: the prohibition applies not only to lay individuals but, with limited exceptions, to corporations and other artificial entities which have no professional rights, privileges or powers under the Medical Practice Act.

And it states the purpose in terms that determine how the doctrine reaches compensation: California policy is against permitting lay persons to practise any of the medical arts or to exercise control over decisions made by healing arts practitioners.

That second limb — control over decisions — is the operative one for this article. A structure in which no lay person practises medicine, and in which physicians hold every clinical title, can still be a structure in which lay decisions determine clinical ones. Whether it does is a question about mechanisms, and compensation is a mechanism.

There is a recognised exemption route. Article 18 provides that section 2400 does not apply to a medical corporation practicing pursuant to the Moscone-Knox Professional Corporation Act (law.justia.com) and that article, subject to its conditions — which is why physician-owned professional corporations are the ordinary vehicle.

Why compensation is the control mechanism that matters

Governance documents allocate authority on paper. Compensation allocates it in practice, and the gap between the two is where this doctrine does its real work.

Consider what a formula actually does. A physician paid per encounter has a financial reason to see more patients in the same hours. A physician paid on collections has a reason to favour better-reimbursed services. A physician whose bonus depends on a utilisation metric has a reason to order less. A physician on a productivity target has a reason to shorten visits.

None of those is inherently improper, and all of them are ordinary features of medical compensation. The point is narrower: each creates a financial consequence attached to a clinical decision, and the party that designed the formula chose which decisions carry which consequence.

Set that against the policy the Board (mbc.ca.gov) articulates — against permitting lay persons to exercise control over decisions made by healing arts practitioners — and the analytical question becomes clear. Not "who owns the entity" but "who set the formula, and what clinical behaviour does it reward."

Three features make compensation more powerful than explicit direction.

It operates continuously rather than case by case. A directive about one patient is visible and contestable; a formula shapes every decision quietly.

It requires no instruction. Nobody tells the physician what to do; the incentive does the work, and the physician experiences the resulting behaviour as their own judgment.

And it is documented as a commercial term rather than as clinical governance, so it escapes the scrutiny that an explicit clinical directive would attract.

That is why an independence clause and an aggressive incentive formula in the same agreement are in tension, and why the formula usually wins.

The MSO structure, and where compensation sits inside it

Because section 2400 (official source) denies corporations professional rights and Article 18 exempts professional corporations practicing under the Moscone-Knox Act (official source), the standard California arrangement separates two entities.

A physician-owned professional medical corporation holds the clinical practice, employs the physicians, and bills for professional services. A management services organisation — which may have lay or investor ownership — provides administrative, financial, and operational support under a management services agreement.

The structure is legitimate and widespread. What determines whether it respects the doctrine is where decisions actually sit.

Compensation is the pressure point for a specific reason: the management fee and the physician compensation pool are connected. Money arriving from professional services funds both, so the fee structure determines what is left, and the compensation formula determines how the remainder is distributed against clinical behaviour.

That means a lay-owned MSO can influence clinical incentives without ever issuing a clinical instruction — by designing a fee arrangement that makes certain clinical patterns financially necessary for the practice, and by supplying the compensation model the practice then adopts.

The questions that matter are therefore mechanical. Who drafted the compensation formula? Can the practice change it without MSO consent? Does the management fee vary with clinical volume or service mix? Who sets productivity targets, and what happens if they are not met? Can the MSO terminate or replace physicians, directly or by declining to support them?

Where the answers place those decisions with the MSO, the arrangement is closer to lay control than its documents suggest — and the physicians are the licensees exposed if the Board (mbc.ca.gov) examines it.

Model by model: where each sits

Working through the common structures against the control question produces different answers, and the differences are usable in negotiation.

Straight salary. The cleanest position. No clinical decision carries a financial consequence for the physician, so the formula exerts no influence on clinical judgment. Note that section 2400 (law.justia.com)’s narrow exception speaks specifically of employment of licensees on a salary basis by licensed charitable institutions, foundations, or clinics where no charge for professional services is made — which indicates that salary was the arrangement the Legislature was prepared to contemplate outside the professional-corporation route.

Productivity-based compensation, typically on work relative value units. Rewards volume of service. The clinical influence is on throughput and on the mix of billable activity, and it penalises time-intensive care that generates little billing — counselling, coordination, complex decision-making. Widespread, and defensible where targets are set by physicians and are achievable without compromising care.

Collections-based compensation. Rewards revenue rather than service, so it attaches financial consequence to payer mix and to the reimbursement level of chosen services. This is closer to the commercial exploitation the Board (official source) identifies as the concern, because the formula rewards profitable clinical choices as such.

Quality or value-based bonuses. The framing is protective, and the analysis depends entirely on the metric. A metric measuring documented process is a documentation incentive. A metric measuring outcomes without case-mix adjustment penalises taking difficult patients.

Utilisation or cost-containment incentives. The most exposed category, because the formula rewards ordering less — and the boundary between eliminating waste and withholding indicated care is drawn by whoever set the target.

The utilisation incentive, examined properly

Cost-containment incentives deserve separate treatment because they are increasingly common and because they invert the physician’s ordinary duty in a specific way.

The legitimate case is strong. Overuse is real, some testing is genuinely low-value, and a system that rewards volume regardless of benefit produces harm as well as cost. Incentives that reward restraint are attempting to correct a real distortion.

The difficulty is that the metric cannot distinguish appropriate restraint from inappropriate restraint. A physician whose bonus depends on ordering fewer scans earns the same reward for declining an unnecessary scan and for declining a necessary one. The formula is indifferent between the two; only the physician’s judgment separates them, and the formula is applying pressure to that judgment.

Three features determine whether such an incentive is defensible.

Who set the target. A target set by physicians reviewing their own practice patterns is professional self-governance. A target set by a lay-owned management entity is a lay decision about clinical thresholds — which is squarely what the Board (mbc.ca.gov) describes California policy as against.

Whether the metric is risk-adjusted. An unadjusted utilisation comparison penalises the physician who takes the sickest patients, which is a perverse clinical incentive independent of any control question.

And whether an override exists without penalty. A physician who can order what they judge necessary without the formula punishing them has retained clinical authority. One who cannot has not, whatever the independence clause says.

That third question is the one worth asking in writing before signing, because the answer is usually not in the document.

What to read in an offer, in order

A physician evaluating an employment or affiliation agreement should read the documents in an order that surfaces the control question rather than burying it.

Start with the entity structure. Who employs you — a professional medical corporation practicing under the Moscone-Knox Act (law.justia.com), or a general corporation or LLC? Given section 2400 (law.justia.com), that answer determines whether the arrangement is on the ordinary California footing at all.

Then the compensation formula, in full, including the appendices. Formulae routinely live in schedules that are drafted later and amended more easily than the body of the agreement.

Then the amendment provision for compensation. A formula the employer may amend unilaterally is not a term you negotiated; it is a term you accepted the future versions of.

Then the targets and metrics, and who sets them. Look specifically for whether targets are set by physicians, whether they are risk-adjusted, and whether they can be revised without your consent.

Then the override question. Can you order, refer, admit, or take the time you judge necessary without the formula penalising you? Ask in writing; the answer is rarely in the document.

Then the management services agreement, if one exists. You may not be a party, and it may nonetheless determine your compensation pool. Ask to see it.

And finally the independence clause — last, because by then you can assess whether it describes the arrangement or contradicts it.

Where the formula and the clause conflict, the formula is what will operate. That is the whole of the practical lesson.

Why the exposure lands on the physician

A structural asymmetry deserves stating plainly, because it explains why this is a physician’s problem rather than a corporate one.

Section 2052 (official source) and section 2400 (official source) operate on licensure and on corporate incapacity. The Medical Board (official source) licenses physicians, and its enforcement authority runs against licensees. The Board’s own enforcement material (official source) addresses unlicensed corporate practice, but the practitioner is the party whose license is at stake in any Board proceeding.

So a physician who participates in an arrangement later characterised as lay-controlled is exposed in a way the lay owners frequently are not — or are exposed differently, through business rather than licensure consequences.

Three practical implications.

Due diligence on the structure is the physician’s own responsibility, not something the employer’s counsel performs on their behalf. Employer counsel represents the employer.

Assurance that an arrangement is standard is not a defence. Prevalence and lawfulness are different questions, and this is an area where widely used structures have been examined.

And a physician serving as a nominal owner or medical director of a practice they do not actually control is in the most exposed position of all — holding the license and the title while lay decisions determine clinical operations.

The instruction follows: before accepting a medical director role or nominal ownership in a structure you did not design, obtain independent counsel who represents you rather than the entity. That is a genuinely different service from having the deal papered.

The case law this rests on

The doctrine is statutory in form and heavily judicial in development, and a physician relying on it should know the shape of that authority rather than only the code sections.

California authority on corporate practice extends back to the 1930s. Secondary accounts identify the foundational medical ruling as _People ex rel. State Board of Medical Examiners v. Pacific Health Corp. (1938) 12 Cal.2d 156, with the doctrine traced earlier to dental practice authority, and a later decision in _Conrad v. Medical Board of California (1996) 48 Cal.App.4th 1038 addressing physician employment outside the narrow statutory exceptions.

Two observations follow, and the second is the more useful.

The age of the authority is a strength rather than a weakness here. A doctrine developed over decades and repeatedly applied is not a novel theory that a well-drafted agreement can be assumed to have anticipated.

And the development has been about arrangements rather than about labels. Cases in this area have concerned whether a particular structure placed clinical practice or clinical control in lay hands, which is a factual inquiry into how an arrangement operated. That is why the questions in this article are mechanical — who set the formula, who can amend it, what happens on an override — rather than definitional.

The legal analysis should rest on current statutory text, official Medical Board guidance, and cases whose holdings have been read in context. Compensation arrangements are intensely fact-specific: the same percentage, productivity formula, management fee, or quality incentive can have different consequences depending on who employs the physician, who controls clinical judgment, how fees are allocated, and whether the structure complies with California’s professional-entity and fee-splitting rules. The authorities below are starting points, not substitutes for review of the actual contracts and corporate relationships.

What is changing, and what to verify

This is an area under active legislative and regulatory attention, and any account of it dates quickly.

Secondary commentary from 2026 describes recent California legislation addressing corporate practice and private-equity involvement in medical practices, including reporting obligations to the Office of Health Care Affordability (official source) and provisions said to constrain management-services arrangements and lay control more tightly than the statutory baseline in section 2400 (official source) alone.

This article does not state the content of that legislation, for a reason worth being explicit about: I have not read the enacted text, and commentary about recent statutes is unreliable in exactly the respects that matter — effective dates, scope of covered entities, and what is actually required rather than recommended.

So the instruction is to verify before relying. Anyone advising on a California management-services arrangement in 2026 should confirm the current statutory position directly, because the baseline described here may have been supplemented.

What does not change with the legislation is the analytical frame. The prohibition has always been about control as well as ownership — the Board (mbc.ca.gov) has long described the policy as against lay persons exercising control over decisions made by healing arts practitioners — and compensation has always been a control mechanism. Legislation tightening the doctrine makes that frame more consequential rather than different.

The practical consequence for a physician: the questions in this article remain the right questions, and the answers may now carry additional regulatory weight for the entities involved.

What a defensible compensation structure looks like

It is easier to criticise these arrangements than to describe a good one, so it is worth being concrete about what respects the doctrine while remaining commercially workable.

Physician-set targets. Where productivity or quality targets are established by a physician body reviewing its own practice patterns, the decision about clinical thresholds sits with licensees. This is the single most important feature, and it is achievable without changing the economics.

A base component substantial enough to live on. Where a physician’s core income does not depend on the formula, the formula influences at the margin rather than governing. Section 2400 (official source)’s own narrow exception contemplates salary, which is a signal about what the Legislature regarded as unobjectionable.

Risk-adjusted metrics with a stated comparison group. Unadjusted comparisons penalise physicians who take complex patients, which is a clinical distortion regardless of who set the metric.

An explicit clinical override with no financial penalty. Written into the compensation schedule rather than gestured at in an independence clause: where the physician judges a service necessary, ordering it does not count against the metric.

Physician consent to amendment. A formula the practice can change only with physician agreement is a formula physicians control.

And a management fee that does not vary with clinical volume or service mix. Where the fee is fixed or cost-based rather than a share of clinical revenue, the management entity has no financial interest in particular clinical choices.

A structure with those six features is defensible on the control question. One lacking most of them is exposed however carefully its professional corporation (official source) paperwork is drafted.

How this connects to the rest of a physician’s exposure

Compensation design does not sit in isolation. It interacts with every other system a physician answers to, and the interactions are where the practical harm accumulates.

With the licensing system. A physician whose care is later examined by the Medical Board (mbc.ca.gov) will be assessed against the standard of care, and the compensation structure that shaped their behaviour is not a defence. A formula rewarding throughput does not excuse a rushed assessment; the physician holds the license and the judgment was theirs in law. That asymmetry — institutional incentive, individual accountability — is the single most important thing to understand about these arrangements.

With peer review. Utilisation-based criticism of a physician who was incentivised toward volume, or quality criticism of a physician incentivised toward restraint, arrives through a process that examines the physician rather than the incentive — the analysis in economic versus patient safety credentialing (Economic vs Patient Safety Credentialing: The Standard Is "Exclusively," and Nobody Cites It).

With the employment relationship. Where the same entity employs the physician and holds the privileging function, the compensation formula and the review process sit with one party — the compression examined in hospital employment and staff independence (Hospital Employment and Staff Independence: Two Relationships, One Employer, and the Question Nobody Asks).

And with documentation. A physician under throughput pressure documents less, and thin documentation is what makes a defensible clinical decision indefensible when examined years later — the point developed in the physician’s written response (The Physician’s Written Response: The Document That Decides Cases Before Anyone Calls It a Case).

The practical instruction: when assessing a compensation formula, ask not only whether it is lawful but what record it will leave. The formula that maximises income frequently minimises the documentation that would later protect you.

What to do if you are already in one

Most physicians reading this are inside an arrangement rather than evaluating one, and the useful advice is different.

Establish what you actually signed. Obtain the current compensation schedule, not the one attached at hire — formulae are amended, and many physicians are operating under terms they have never read. Ask for the management services agreement if one exists.

Document where the incentive and your judgment diverge. Where you order, refer, or spend time against the formula’s pull, note it. That record does two things: it demonstrates that clinical judgment governed your decisions, and in aggregate it evidences that the formula was exerting pressure.

Raise structural concerns through clinical governance, in writing, as patient safety matters. A concern that a utilisation target is affecting care belongs in the quality process, not in a compensation discussion. Routing it correctly creates a contemporaneous record and makes it much harder to characterise later as a personal grievance.

Use whatever physician governance exists. Where targets are set by a physician body, participate in setting them. Where they are not, that is the finding — and it is worth stating in writing that clinical thresholds are being set outside the physician group, given the policy the Board (mbc.ca.gov) articulates.

And get independent advice before renewal rather than at exit. The renewal is the negotiation; the exit is the consequence. A physician who asks these questions at renewal has leverage. One who asks them while leaving has a grievance.

What not to do: treat the formula as immutable because it is standard. Prevalence is not lawfulness, and it is not a reason not to ask.

A note for journalists

Physician compensation is reported badly in a consistent pattern, and two distinctions prevent most of the errors.

Ownership and control are different questions. A story establishing that a private equity firm owns a management company has not established that the firm practises medicine or controls clinical decisions — and section 2400 (law.justia.com) addresses professional rights and powers rather than investment. The reportable question is mechanical: who sets the clinical targets, who can amend the compensation formula, and what happens when a physician orders against the incentive.

Incentives are not inherently improper. Productivity and quality components are ordinary features of medical compensation, and a story treating any incentive as evidence of corporate interference will be both inaccurate and easy for the industry to rebut. What distinguishes the cases is who designed the metric and whether clinical override carries a penalty.

Three further points. The Medical Board’s own enforcement material (mbc.ca.gov) is the best available primary statement of the policy — that California is against lay persons exercising control over decisions made by healing arts practitioners — and it is quotable. Physicians bear the licensure exposure while entities bear business exposure, so the incentive to speak on the record is asymmetric and sourcing will be difficult. And the area is under active legislative change, with reporting obligations to the Office of Health Care Affordability (hcai.ca.gov), so any account should state the date of the law it describes.

The verifiable questions are documentary: what does the compensation schedule say, who may amend it, who sets the targets, and does the management fee vary with clinical volume.

Non-compete and restrictive terms as control

Compensation is the primary control mechanism, and it operates alongside a second that physicians price even less accurately: the terms governing departure.

Restrictive covenants, notice periods, repayment obligations for signing bonuses or relocation, and forfeiture of accrued incentive compensation on exit all have the same effect. They raise the cost of leaving, and a physician who cannot afford to leave has less practical ability to resist pressure on clinical judgment.

That matters for the control analysis rather than only for the physician’s finances. The Board (mbc.ca.gov)’s stated concern is lay persons exercising control over decisions made by healing arts practitioners. A physician whose exit is prohibitively expensive is more susceptible to a formula they consider clinically distorting, because the ordinary remedy — leaving — is foreclosed.

Four terms are worth locating specifically.

Forfeiture of earned incentive compensation on departure, which converts accrued pay into a retention device.

Repayment obligations triggered by resignation within a stated period, and whether they are prorated.

Notice periods long enough that a physician cannot practically accept another position.

And any provision conditioning continued employment on meeting the compensation formula’s targets, which converts an incentive into a requirement.

California law on the enforceability of restrictive covenants against employees is its own subject and is not stated here. The narrower point stands regardless: departure costs are part of how much practical independence a compensation formula leaves you, and they should be read at the same time as the formula rather than at exit — which is the pattern examined in hospital employment and staff independence (Hospital Employment and Staff Independence: Two Relationships, One Employer, and the Question Nobody Asks).

Telehealth and multi-state arrangements

A growing category of arrangement stresses this doctrine in a way the case law did not anticipate, and physicians entering it frequently do not realise California law applies.

Telehealth platforms commonly operate as a lay-owned technology and management company contracting with physician entities across multiple states. The physician sees patients remotely, the platform sets the visit structure, the scheduling, the documentation template, the formulary options, and the compensation — typically per consultation.

Three features make this the sharpest version of the control problem.

The platform designs the clinical workflow. Visit length, what questions are asked, what the interface permits ordering, and how much time a consultation allows are product decisions made by a lay-owned company, and they determine clinical practice more directly than any compensation formula. A platform that structures a consultation to be completed in a set number of minutes has made a clinical decision.

Per-consultation compensation rewards throughput at the point where throughput is most tightly controlled by someone else.

And the physician is licensed in California and treating California patients, so section 2400 (official source) and section 2052 (official source) are engaged regardless of where the platform is incorporated. Being a small part of a national operation does not change the licensee’s position.

The questions to ask are the same mechanical ones, applied to the product rather than the pay: who determines the consultation structure, can I extend a visit or decline to prescribe without consequence, and can I order or refer outside what the interface offers.

Where the answer is that the workflow is fixed and deviation is penalised, the arrangement places clinical decisions with the platform — and the physician holds the license.

The nominal owner problem

One arrangement produces the worst exposure available under this doctrine, and physicians accept it routinely because the money is good and the responsibility looks light.

The structure: a physician holds the shares of a professional medical corporation and the title of owner or medical director. A lay-owned management company supplies everything else — capital, premises, staff, systems, billing, marketing, and the compensation model. The physician receives a stipend, spends limited time on the practice, and does not control its operations.

This satisfies the ownership requirement on paper. Article 18 (official source) exempts professional corporations from section 2400 (official source), and the shares are held by a licensee.

It fails the question the doctrine actually asks. If the physician does not control clinical operations, someone else does, and that someone is a lay entity — which is what the Board (mbc.ca.gov) describes California policy as prohibiting.

The exposure is asymmetric and severe. The physician holds the license, the title, and the signature on the governing documents. If the arrangement is examined, they are the party who represented that they owned and controlled a medical practice.

Four questions identify the problem before it is yours. What decisions do I actually make? Can I hire, fire, or set clinical protocols? Can I terminate the management agreement, and on what notice? And if I resigned tomorrow, would the practice continue unchanged with a different physician in my seat?

That last question is diagnostic. Where the answer is yes — the practice runs the same way with any licensee in the chair — the physician is supplying a license rather than practicing medicine, and the arrangement is what the doctrine exists to reach.

What the doctrine cannot fix

A closing limit, because this doctrine is sometimes offered to physicians as a remedy and it is not one.

It does not give a physician a cause of action against an employer. Section 2400 (official source) denies corporations professional powers and section 2052 (official source) prohibits unlicensed practice; neither creates an entitlement a physician can enforce against a compensation formula they dislike. Whether any private remedy exists in a given situation is a question for counsel and is not assumed here.

It does not make an unwelcome incentive unlawful. Productivity targets, quality metrics, and utilisation measures are ordinary and mostly lawful. The doctrine addresses control over clinical decisions, not the existence of financial pressure, and a physician who invokes it against every incentive will be dismissed.

It does not protect a physician from the consequences of their own clinical decisions. This is the most important limit. A physician whose care is examined by the Board (official source) is assessed against the standard of care, and the formula that pushed them toward a shorter visit or a declined test is not a defence. The policy (official source) the doctrine expresses is about protecting patients from commercial exploitation of practice, not about excusing practitioners.

And it does not operate without someone raising it. Enforcement is episodic and structures are widespread.

So the doctrine’s practical value to an individual physician is analytical rather than remedial. It supplies the right question to ask about an arrangement before joining it, and a vocabulary for raising concerns inside one. It does not supply a way out of an arrangement already accepted, which is why the reading should happen before signature.

For physicians designing a group’s compensation

Most of this article addresses the physician receiving a formula. Some readers will be writing one, and the doctrine reads differently from that side.

The first observation is protective. Where a physician group sets its own targets and formula, the control question largely resolves itself — clinical thresholds are being set by licensees, which is what section 2400 (law.justia.com) and the Board’s policy (mbc.ca.gov) contemplate. A group that retains genuine authority over its compensation design has removed the doctrine’s sharpest edge before any lawyer looks at the documents.

The second is that retaining that authority requires writing it down. Where a management agreement permits the management entity to propose, approve, or veto compensation changes, the group has ceded the decision whatever its internal practice. The provision to insist on is that compensation design requires physician consent and cannot be amended without it.

The third is that internal fairness and the doctrine point the same way. A formula set by a small leadership group and imposed on employed physicians within the practice reproduces the control problem one level down — licensees deciding for other licensees is better than lay control, but a process that involves the physicians measured by the metric produces both better metrics and a more defensible arrangement.

And the fourth is documentation. Minute the decisions: who set the targets, on what clinical reasoning, with what risk adjustment, and what override exists. A group that can show its compensation design was a clinical governance decision has the record the doctrine asks for. One that cannot will be assessed on the structure (official source) alone, which is the weaker ground.

The one question that resolves most cases

If a physician takes a single test from this article into an offer or an existing arrangement, it should be this: if I exercise clinical judgment against the incentive, what does it cost me?

That question is diagnostic because it isolates the element the doctrine actually addresses. Section 2400 (official source) denies corporations professional rights, privileges, or powers, and the Board (official source) describes the policy as against lay persons exercising control over decisions made by healing arts practitioners. Control means that a decision has a consequence attached by someone else.

Ask it concretely, in writing, with examples drawn from your own practice. If this patient needs a longer visit than the target allows, what happens? If I order the scan the protocol discourages, what happens? If I refer outside the network because the patient needs it, what happens? If I decline to prescribe on a telehealth consultation, what happens?

Four kinds of answer are possible, and they sort the arrangement.

Nothing happens — clinical judgment governs and the formula adjusts. This is the defensible position.

It costs me money at the margin, but I can afford it. Ordinary and workable, provided the margin is genuinely marginal.

It costs enough that I would think twice. The formula is now governing clinical decisions, which is the problem this doctrine names.

Nobody will answer in writing. Treat that as the most informative response available, and as a reason to have counsel who represents you read the whole arrangement before you sign it.

Everything else in this article is elaboration of that one question.

Where this leaves the physician

A summary of the position, because the analysis is uncomfortable and the practical conclusion is narrow.

California gives physicians a genuinely strong doctrine on paper. Section 2400 (official source) denies corporations professional rights, privileges, or powers, and the Medical Board (official source) describes state policy as against lay persons exercising control over decisions made by healing arts practitioners, with the bar designed to protect the public from commercial exploitation of the practice of medicine. That is a stronger statement of professional independence than most jurisdictions offer.

What the doctrine does not supply is a mechanism the individual physician can operate. Enforcement runs through the Board (official source) against licensees, not through physicians against employers. So a physician in a compensation structure they consider clinically distorting has a principle rather than a remedy.

What they do have is three things worth using.

A question that surfaces the issue before signature, and that a well-run organisation will answer.

A vocabulary for raising concerns internally as clinical governance rather than as a pay dispute — which is both more accurate and considerably harder to dismiss.

And a reason to insist that clinical targets be set by physicians, which is achievable, costs the organisation nothing, and resolves most of the control problem at source.

The honest conclusion: the doctrine is better understood as a design standard for arrangements than as a shield for individuals. Physicians who use it at the design stage get its benefit. Physicians who reach for it after the fact usually find it does not reach far enough.

Before signing

Establish which entity employs you — a professional medical corporation under Moscone-Knox, or a general corporation or LLC.

Read the compensation formula in full, including schedules and appendices drafted separately from the agreement.

Check whether the formula can be amended unilaterally; if it can, you did not negotiate it.

Establish who sets the targets and metrics, and whether physicians can revise them without outside consent.

Ask in writing whether you can order, refer, admit, or take the time you judge necessary without the formula penalising you.

Ask to see any management services agreement, even where you are not a party — it may determine your compensation pool.

Check whether the management fee varies with clinical volume or service mix.

Confirm any quality or utilisation metric is risk-adjusted and against what comparison group.

Retain counsel who represents you rather than the entity before accepting nominal ownership or a medical director role.

Verify the current statutory position — California corporate practice law has been the subject of recent legislation.

Read the formula, not the clause

Every California physician employment agreement contains a professional-independence clause stating that clinical decisions rest with the physician. Almost none of them are false. They are simply not where control is exercised.

Control is exercised by the compensation formula, because a formula attaches a financial consequence to each clinical decision, operates continuously, requires no instruction, and is documented as a commercial term rather than as clinical governance. Where the formula and the clause point in different directions, the formula is what will shape behaviour.

So the assessment a physician should make is mechanical rather than interpretive: who designed the formula, who can change it, who sets the targets, and whether exercising clinical judgment against the incentive costs you money. Those four answers describe the arrangement more accurately than any recital of professional independence.

General educational information—not legal or medical advice

This article describes California statutory structure and Medical Board enforcement policy for physicians, health lawyers, and administrators. It is not legal advice and creates no professional relationship. California corporate practice law has been the subject of recent legislation whose enacted text is not stated here, structures vary enormously, and whether a particular arrangement is compliant is a fact-specific question. Any physician evaluating an employment, affiliation, or management arrangement should retain counsel who represents them personally and who has confirmed the current statutory position.

Questions worth asking

Which entity employs me, and is it a professional corporation practicing under Moscone-Knox?

Who drafted the compensation formula, and can it be amended without my consent?

Who sets the productivity, quality, or utilisation targets I am measured against?

Is any metric risk-adjusted, and against which comparison group?

If I order what I judge necessary against the incentive, what does it cost me?

Does the management fee vary with clinical volume or service mix?

If I am the nominal owner or medical director, what decisions do I actually control?

Takeaway

California’s corporate practice prohibition is about control as much as ownership — the Medical Board describes the policy as against lay persons exercising control over decisions made by healing arts practitioners, and section 2400 denies corporations professional rights, privileges, or powers. Compensation is the most powerful control mechanism available, because it attaches financial consequence to clinical decisions continuously and without instruction. So the questions that matter are who designed the formula, who can change it, who sets the targets, and what exercising clinical judgment against the incentive costs — not what the independence clause says.

Sources and Authorities

The sources below are provided so readers can confirm the governing text and current agency guidance. Laws, regulations, agency pages, and implementation dates can change; time-sensitive requirements should be checked against the current official source.

WHO — Global Patient Safety Action Plan 2021–2030 — who.int

Case opinion — law.justia.com

leginfo.legislature.ca.gov — leginfo.legislature.ca.gov

mbc.ca.gov — mbc.ca.gov

Case opinion — law.justia.com

www.mbc.ca.gov — mbc.ca.gov

leginfo.legislature.ca.gov — leginfo.legislature.ca.gov

leginfo.legislature.ca.gov — leginfo.legislature.ca.gov

Related Articles

• Productivity Targets and Independence
• Who Controls Clinical Judgment
• Hospital Employment and Staff Independence: Two Relationships, One Employer, and the Question Nobody Asks